Enhancement of Peroxydisulfate Activation for Complete Degradation of Refractory Tetracycline by 3D Self-Supported MoS2/MXene Nanocomplex
Nanomaterials · 30.04.2024 · 14 (9) · 786
DOI: 10.3390/nano14090786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanomaterials, online erschienen am 30.04.2024. Verfasst von Yuxia Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life and Environmental Sciences, Central South University of Forestry and Technology, Changsha 410004, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Hunan, China, the Research Foundation of Education Bureau of Hunan, China, the Major program Natural Science Foundation of Hunan, China.
Abstract (Originalsprache)
Antibiotic abuse, particularly the excessive use of tetracycline (TC), a drug with significant environmental risk, has gravely harmed natural water bodies and even posed danger to human health. In this study, a three-dimensional self-supported MoS2/MXene nanohybrid with an expanded layer spacing was synthesized via a facile one-step hydrothermal method and used to activate peroxydisulfate (PDS) for the complete degradation of TC. The results showed that a stronger •OH signal was detected in the aqueous solution containing MoS2/MXene, demonstrating a superior PDS activation effect compared to MoS2 or Ti3C2TX MXene alone. Under the conditions of a catalyst dosage of 0.4 g/L, a PDS concentration of 0.4 mM, and pH = 5.0, the MoS2/MXene/PDS system was able to fully eliminate TC within one hour, which was probably due to the presence of several reactive oxygen species (ROS) (•OH, SO4•−, and O2•−) in the system. The high TC degradation efficiency could be maintained under the influence of various interfering ions and after five cycles, indicating that MoS2/MXene has good anti-interference and reusability performance. Furthermore, the possible degradation pathways were proposed by combining liquid chromatography–mass spectrometry (LC-MS) data and other findings, and the mechanism of the MoS2/MXene/PDS system on the degradation process of TC was elucidated by deducing the possible mechanism of ROS generation in the reaction process. All of these findings suggest that the MoS2/MXene composite catalyst has strong antibiotic removal capabilities with a wide range of application prospects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life and Environmental Sciences, Central South University of Forestry and Technology, Changsha 410004, China.
ORCID-Profile: Yuxia Song
Förderung
- the Natural Science Foundation of Hunan, China
- the Research Foundation of Education Bureau of Hunan, China
- the Major program Natural Science Foundation of Hunan, China
- the Science and Technology Talent Support Project of Hunan, China
- the National Natural Science Foundation of China
- the Environmental Research Foundation of Hunan, China
- the Natural Science Foundation of Hunan Province
- Scientific Research Project of Education Department of Hunan Province
Zitieren
APA
Song, Y., Chen, R., Li, S., Yu, S., Ni, X., Fang, M., & Xie, H. (2024). Enhancement of Peroxydisulfate Activation for Complete Degradation of Refractory Tetracycline by 3D Self-Supported MoS2/MXene Nanocomplex. Nanomaterials, 14(9), 786. https://doi.org/10.3390/nano14090786
Vancouver
Song Y, Chen R, Li S, Yu S, Ni X, Fang M, et al. Enhancement of Peroxydisulfate Activation for Complete Degradation of Refractory Tetracycline by 3D Self-Supported MoS2/MXene Nanocomplex. Nanomaterials. 2024;14(9):786. doi:10.3390/nano14090786
BibTeX
@article{Song2024,
author = {Song, Yuxia and Chen, Runhua and Li, Shihai and Yu, Shali and Ni, Xiaoli and Fang, Minglong and Xie, Hanyun},
title = {Enhancement of Peroxydisulfate Activation for Complete Degradation of Refractory Tetracycline by 3D Self-Supported MoS2/MXene Nanocomplex},
journal = {Nanomaterials},
year = {2024},
volume = {14},
number = {9},
pages = {786},
doi = {10.3390/nano14090786}
}
EUVIMED